Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome

Endocrine

Volumn 53, Issue 1, 2016, Pages 271-279

  Calan, Mehmet ^a   Yilmaz, Ozgur ^b   Kume, Tuncay ^a   Unal Kocabas, Gokcen ^c   Yesil Senses, Pinar ^d   Senses, Yasar Mehmet ^d   Temur, Muzaffer ^b   Gursoy Calan, Ozlem ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Department of Obstetrics and Gynecology   (Turkey)

^c UNIVERSITY OF HEALTH SCIENCES   (Turkey)

^d EGE UNIVERSITY   (Turkey)

Author keywords

Betatrophin; Free testosterone; Insulin resistance; Lipids; Polycystic ovary syndrome

Indexed keywords

BETATROPHIN; C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; HORMONE; INSULIN; LIPID; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; BLOOD; METABOLISM; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADULT; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; PEPTIDE HORMONES; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; YOUNG ADULT;

EID: 84975811149     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-0875-z     Document Type: Article

References (36)

1. D.A. Ehrmann, Polycystic ovary syndrome. N. Engl. J. Med. 352, 1223–1236 (2005)
2. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)
3. R.S. Legro, S.A. Arslanian, D.A. Ehrmann, K.M. Hoeger, M.H. Murad, R. Pasquali, C.K. Welt, Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98, 4565–4592 (2013)
4. C.N. Jayasena, S. Franks, The management of patients with polycystic ovary syndrome. Nat. Rev. Endocrinol. 10, 624–636 (2014)
5. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit, R. Lobo, R.J. Norman, E. Talbott, D.A. Dumesic, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010)
6. H. Mani, M.J. Levy, M.J. Davies, D.H. Morris, L.J. Gray, J. Bankart, H. Blackledge, K. Khunti, T.A. Howlett, Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin. Endocrinol. (Oxf) 78, 926–934 (2013)
7. C.G. Solomon, F.B. Hu, A. Dunaif, J.E. Rich-Edwards, M.J. Stampfer, W.C. Willett, F.E. Speizer, J.E. Manson, Menstrual cycle irregularity and risk for future cardiovascular disease. J. Clin. Endocrinol. Metab. 87, 2013–2017 (2002)
8. A. Dokras, Cardiovascular disease risk in women with PCOS. Steroids 78, 773–776 (2013)
9. L.K. Hoffman, D.A. Ehrmann, Cardiometabolic features of polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 4, 215–222 (2008)
10. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, R. Azziz, Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7, 219–231 (2011)
11. G. Ren, J.Y. Kim, C.M. Smas, Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 303, E334–E351 (2012)
12. R. Zhang, Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem. Biophys. Res. Commun. 424, 786–792 (2012)
13. F. Quagliarini, Y. Wang, J. Kozlitina, N.V. Grishin, R. Hyde, E. Boerwinkle, D.M. Valenzuela, A.J. Murphy, J.C. Cohen, H.H. Hobbs, Atypical angiopoietin-like protein that regulates ANGPTL3. Proc. Natl. Acad. Sci. USA 109, 19751–19756 (2012)
14. P. Yi, J.-S. Park, D.A. Melton, Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 153, 747–758 (2013)
15. Y. Wang, F. Quagliarini, V. Gusarova, J. Gromada, D.M. Valenzuela, J.C. Cohen, H.H. Hobbs, Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc. Natl. Acad. Sci. USA 110, 16109–16114 (2013)
16. D. Weissglas-Volkov, C.A. Aguilar-Salinas, E. Nikkola, K.A. Deere, I. Cruz-Bautista, O. Arellano-Campos, L.L. Muñoz-Hernandez, L. Gomez-Munguia, M.L. Ordoñez-Sánchez, P.M.V.L. Reddy, A.J. Lusis, N. Matikainen, M.-R. Taskinen, L. Riba, R.M. Cantor, J.S. Sinsheimer, T. Tusie-Luna, P. Pajukanta, Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J. Med. Genet. 50, 298–308 (2013)
17. G.M. Peloso, P.L. Auer, J.C. Bis, A. Voorman, A.C. Morrison, N.O. Stitziel, J.A. Brody, S.A. Khetarpal, J.R. Crosby, M. Fornage, A. Isaacs, J. Jakobsdottir, M.F. Feitosa, G. Davies, J.E. Huffman, A. Manichaikul, B. Davis, K. Lohman, A.Y. Joon, A.V. Smith, M.L. Grove, P. Zanoni, V. Redon, S. Demissie, K. Lawson, U. Peters, C. Carlson, R.D. Jackson, K.K. Ryckman, R.H. Mackey, J.G. Robinson, D.S. Siscovick, P.J. Schreiner, J.C. Mychaleckyj, J.S. Pankow, A. Hofman, A.G. Uitterlinden, T.B. Harris, K.D. Taylor, J.M. Stafford, L.M. Reynolds, R.E. Marioni, A. Dehghan, O.H. Franco, A.P. Patel, Y. Lu, G. Hindy, O. Gottesman, E.P. Bottinger, O. Melander, M. Orho-Melander, R.J.F. Loos, S. Duga, P.A. Merlini, M. Farrall, A. Goel, R. Asselta, D. Girelli, N. Martinelli, S.H. Shah, W.E. Kraus, M. Li, D.J. Rader, M.P. Reilly, R. McPherson, H. Watkins, D. Ardissino, NHLBI GO Exome Sequencing Project, Q. Zhang, J. Wang, M.Y. Tsai, H.A. Taylor, A. Correa, M.E. Griswold, L.A. Lange, J.M. Starr, I. Rudan, G. Eiriksdottir, L.J. Launer, J.M. Ordovas, D. Levy, Y.D.I. Chen, A.P. Reiner, C. Hayward, O. Polasek, I.J. Deary, I.B. Borecki, Y. Liu, V. Gudnason, J.G. Wilson, C.M. van Duijn, C. Kooperberg, S.S. Rich, B.M. Psaty, J.I. Rotter, C.J. O’Donnell, K. Rice, E. Boerwinkle, S. Kathiresan, L.A. Cupples, Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 94, 223–232 (2014)
18. V. Gusarova, C.A. Alexa, E. Na, P.E. Stevis, Y. Xin, S. Bonner-Weir, J.C. Cohen, H.H. Hobbs, A.J. Murphy, G.D. Yancopoulos, J. Gromada, ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 159, 691–696 (2014)
19. D. Espes, M. Martinell, P.-O. Carlsson, Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int. J. Endocrinol. 2014, 323407 (2014)
20. A. Fenzl, B.K. Itariu, L. Kosi, M. Fritzer-Szekeres, A. Kautzky-Willer, T.M. Stulnig, F.W. Kiefer, Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57, 1204–1208 (2014)
21. J. Gomez-Ambrosi, E. Pascual, V. Catalan, A. Rodriguez, B. Ramirez, C. Silva, M.J. Gil, J. Salvador, G. Fruhbeck, Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J. Clin. Endocrinol. Metab. 99, E2004–E2009 (2014)
22. T. Gao, K. Jin, P. Chen, H. Jin, L. Yang, X. Xie, M. Yang, C. Hu, X. Yu, Circulating betatrophin correlates with triglycerides and postprandial glucose among different glucose tolerance statuses-a case-control study. PLoS One 10, e0133640 (2015)
23. R. Tarlatzis, B. Fauser, J. Chang, R. Azziz: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM-. Hum. Reprod. (2004)
24. D. Ferriman, J.D. Gallwey, Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440–1447 (1961)
25. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)
26. M.H. Shanik, Y. Xu, J. Skrha, R. Dankner, Y. Zick, J. Roth, Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31, S262–S268 (2008)
27. E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981–1030 (2012)
28. P.M. Catalano, Trying to understand gestational diabetes. Diab. Med. 31, 273–281 (2014)
29. F. Ovalle, Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil. Steril. 77, 1095–1105 (2002)
30. A. Dunaif, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis 1. Endocr. Rev. 18, 774–800 (1997)
31. H. Hu, W. Sun, S. Yu, X. Hong, W. Qian, B. Tang, D. Wang, L. Yang, J. Wang, C. Mao, L. Zhou, G. Yuan, Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diab. Care 37, 2718–2722 (2014)
32. M. Abu-Farha, J. Abubaker, I. Al-Khairi, P. Cherian, F. Noronha, F.B. Hu, K. Behbehani, N. Elkum, Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance. Sci. Rep. 5, 10949 (2015)
33. N. Wawrusiewicz-Kurylonek, B. Telejko, M. Kuzmicki, A. Sobota, D. Lipinska, J. Pliszka, B. Raczkowska, P. Kuc, R. Urban, J. Szamatowicz, A. Kretowski, P. Laudanski, M. Gorska, Increased maternal and cord blood betatrophin in gestational diabetes. PLoS One 10, e0131171 (2015)
34. O. Erol, H.Y. Ellidağ, H. Ayık, M.K. Özel, A.U. Derbent, N. Yılmaz, Evaluation of circulating betatrophin levels in gestational diabetes mellitus. Gynecol. Endocrinol. 31, 1–5 (2015)
35. T. Ebert, S. Kralisch, U. Wurst, U. Lössner, J. Kratzsch, M. Blüher, M. Stumvoll, A. Tönjes, M. Fasshauer, Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur. J. Endocrinol. 173, 1–7 (2015)
36. X. Chen, P. Lu, W. He, J. Zhang, L. Liu, Y. Yang, Z. Liu, J. Xie, S. Shao, T. Du, X. Su, X. Zhou, S. Hu, G. Yuan, M. Zhang, H. Zhang, L. Liu, D. Wang, X. Yu, Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J. Clin. Endocrinol. Metab. 100, E96–E100 (2015)